meai was an early candidate of alcohol replacement drugs that came to market during a late 2010s movement to replace alcohol with less-toxic alternatives spearheaded by british psychopharmacologist david nutt. though meai was made commercially available online in the united states as "pace", nutt's commercial efforts moved away from direct marketing of meai in favor of alcarelle.